Gustafsson, Anna
Garre, Elena
Leiva, Maria Carmen
Salerno, Simona
Ståhlberg, Anders
Landberg, Göran
Article History
Received: 8 March 2021
Accepted: 8 June 2021
First Online: 25 June 2021
Competing interests
: The authors A.G, E.G, M.C.L and S.S declare no potential conflict of interests. A.S and G.L are shareholders and board members of iScaff Pharma AB. The approach using patient-derived scaffolds are patent pending (WO 2018/083231 A1). G.L is shareholder and board member of Sortina Pharma AB. A.S is shareholder and board member of SiMSen Diagnostics and shareholder in TATAA Biocenter.